Operating Company Healthcare

Laborie

Portsmouth, New Hampshire, United States

Privately owned by Patricia Industries, Laborie is a global medical technology company that develops, manufactures, and markets diagnostic and therapeutic equipment and consumables for urology, urogynecology, gastroenterology, obstetrics, gynecology, and neonatal health.

Focus Areas
Urology, Urogynecology, Gastroenterology
Website
www.laborie.com

Tracked deals

6

6 tracked deals across 2019-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

3 buyout · 2 addon · 1 divestiture

Laborie Acquisition Volume by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Laborie. 1 2019 1 2021 1 2022 2 2023 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Laborie Acquires the JADA® System from Organon
    January 28, 2026
    Buyer
    Laborie Medical Technologies
    Target
    JADA System
    Seller
    Organon
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Divestiture

    Laborie Medical Technologies has completed the acquisition of the JADA® System and the team behind it from Organon in a transaction announced in late January 2026. The deal — part of Organon’s divestiture program (previously disclosed as up to $465 million) — brings more than 90 employees and an FDA-cleared device for rapid control of postpartum hemorrhage into Laborie’s obstetrics portfolio to expand the company’s maternal health capabilities.

  • Laborie Medical Technologies Acquires Urotronic
    October 27, 2023
    Buyer
    Laborie Medical Technologies, Patricia Industries
    Target
    Urotronic, Inc.
    Industry
    Medical Devices
    Location
    Minnesota, United States
    Type
    Buyout

    Laborie Medical Technologies has completed the acquisition of Urotronic, a Plymouth, Minnesota-based developer of the Optilume drug‑coated balloon technology for interventional urology. The deal includes an upfront cash payment (net $232 million to Laborie considering its prior minority stake) and up to $345 million in milestone payments, and brings Urotronic and its employees fully into Laborie to expand Laborie's interventional urology product portfolio globally.

  • Laborie Medical Technologies Acquires Novonate (LifeBubble)
    February 14, 2023
    Buyer
    Laborie Medical Technologies Corp.
    Target
    Novonate, Inc.
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Buyout

    Laborie Medical Technologies has acquired Novonate, Inc. and its LifeBubble umbilical catheter securement system to expand Laborie's obstetrics, gynecology and neonatal product portfolio. Novonate, founded in 2017 and based in South San Francisco, developed LifeBubble to improve safety and securement of umbilical catheters in NICUs.

  • Laborie Medical Technologies Acquires GI Supply
    April 20, 2022
    Buyer
    Laborie Medical Technologies Corp., Patricia Industries, Signet Healthcare Partners
    Target
    GI Supply
    Industry
    Medical Devices
    Location
    Pennsylvania, United States
    Type
    Addon

    Laborie Medical Technologies has completed the acquisition of GI Supply, a specialist maker of endoscopy and paracentesis products. GI Supply and its employees will be fully integrated into Laborie to expand the company's gastroenterology product portfolio and commercial capabilities; the deal is supported by Laborie's majority owner Patricia Industries and growth-equity partner Signet Healthcare Partners.

  • Laborie Medical Technologies Acquires Pelvalon
    October 13, 2021
    Buyer
    Laborie Medical Technologies Corp.
    Target
    Pelvalon, Inc.
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Buyout

    Laborie Medical Technologies Corp., a specialist medical technology company headquartered in Portsmouth, New Hampshire, has acquired Pelvalon, Inc., a Redwood City, California-based medical device company. Pelvalon’s Eclipse System is an FDA-cleared, non-surgical, patient-controlled device for women with fecal incontinence; the acquisition expands Laborie’s portfolio in pelvic floor and women’s health therapies.

  • LABORIE Medical Technologies Acquires Clinical Innovations for $525M
    December 20, 2019
    Buyer
    LABORIE Medical Technologies, Patricia Industries
    Target
    Clinical Innovations
    Seller
    EQT Mid Market US, EQT Mid Market Asia III, Funds managed by EQT
    Industry
    Medical Devices
    Location
    Utah, United States
    Type
    Addon

    LABORIE Medical Technologies, a Patricia Industries portfolio company, has completed the acquisition of Clinical Innovations from funds managed by EQT for an enterprise value of $525 million. Clinical Innovations, headquartered in Salt Lake City, Utah, is a leading provider of single-use medical devices for labor & delivery and neonatal intensive care and will form a stand-alone Maternal and Child Health global business unit within LABORIE.

Related Acquisition Pages

Medical Devices Buyers & Acquisitions 6 tracked deals by Laborie. Acquisitions in California 3 tracked deals by Laborie. Acquisitions in Minnesota 1 tracked deal by Laborie. Acquisitions in Pennsylvania 1 tracked deal by Laborie. Acquisitions in Utah 1 tracked deal by Laborie.

Related articles

Selling a company? Get in front of buyers like Laborie

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →